Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

Using Dichoptic Therapy to Treat Intermittent Exotropia

NCT: NCT06529016 · COMPLETED

NCT IDNCT06529016
StatusCOMPLETED
Start Date2024-07-26
Completion2026-04-14
SponsorVirginia Commonwealth University (OTHER)
First posted
Last updated

Brief Summary

Intermittent exotropia is difficult to treat. The mainstay of treatment involves surgery, and in one long-term study authors found that as many as 60% of IXT required at least one re-operation.Patching of the non-dominant eye has also been tested in a large, multi-center randomized control trial and was not found to have a large benefit. More non-surgical treatment modalities are critical to improve the care in this condition.

Frequently Asked Questions

What is Using Dichoptic Therapy to Treat Intermittent Exotropia?

Using Dichoptic Therapy to Treat Intermittent Exotropia is a clinical trial registered under NCT06529016. Current status: COMPLETED.

What is the status of NCT06529016?

The current status of NCT06529016 (Using Dichoptic Therapy to Treat Intermittent Exotropia) is: COMPLETED.

When did Using Dichoptic Therapy to Treat Intermittent Exotropia start?

Using Dichoptic Therapy to Treat Intermittent Exotropia started on 2024-07-26.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.

↑